## Gene Summary
IL21R, also known as the Interleukin 21 Receptor, is a crucial component of the immune system. It encodes a protein that is part of the type I cytokine receptor family, which is expressed on T, B, and natural killer (NK) cells. IL21R primarily binds interleukin 21 (IL-21), leading to a cascade of signals that influence lymphocyte proliferation, differentiation, and apoptosis. These processes are particularly significant in the modulation of immune response and have roles in both innate and adaptive immunity.

## Gene Drugs, Diseases, Phenotypes, and Pathways
The IL21R gene is implicated in various immune-related disorders, notably due to its influence on diverse cell types within the immune system. While specific drugs targeting IL21R directly are under preliminary stages of investigation, this receptor's modulation is considered a potential therapeutic strategy in treating autoimmune diseases, such as rheumatoid arthritis and psoriasis, as well as certain types of cancer. The IL21R and its ligand, IL-21, participate in key signaling pathways, including the JAK-STAT pathway, which is fundamental for transmitting information received from extracellular chemical signals to within the cell, thereby influencing DNA transcription.

## Pharmacogenetics
Pharmacogenetics research for IL21R is in its nascent stages with a growing interest due to the receptor's significant role in modulating the immune response. Although there are no widely established pharmacogenetic associations involving specific drugs and IL21R modifications, research into how variations in this gene affect responses to drugs for autoimmune and inflammatory diseases is ongoing. Understanding individual differences in the IL21R gene could eventually lead to more personalized treatments in immunotherapy, focusing on IL21R's interaction with various biological agents and prospective pharmaceutical compounds.